Nuron Biotech Inc. Information

View Top Employees from Nuron Biotech Inc.

Nuron Biotech markets and develops vaccines for the prevention and treatment of infectious diseases. We have commercial operations in Europe and around the globe through which we currently market Meningitec. Our lead development candidate is NU300, a Haemophilus influenzae type b conjugate vaccine (formerly marketed by Wyeth as HibTITER® ).

Website	https://www.nuronbiotech.com
Revenue	$8.2 million
Funding	$102.7 million
Employees	5 (0 on RocketReach)
Founded	2010
Address	1 East Uwchlan Ave, Exton, Pennsylvania 19341, US
Phone	+1 856-764-7116
Fax	(610) 968-6650
Technologies	JavaScript , HTML , Twitter +450 more (view full list)
Industry	Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering, Health Care, Drug Manufacturing & Research, Medical
Keywords	Vaccine Development, Therapeutic Vaccines, Vaccine Research, Pharmaceutical Research, Biotechnology, Immunology, Drug Development, Clinical Trials, Global Health, Pharmaceutical, Health Care, Biotech, Medicine, Disease Prevention, Public Health
Competitors	Amgen, Genentech, Regeneron, Novartis, Johnson & Johnson, Bristol Myers Squibb, Merck & Co., Inc., Gilead Sciences, Pfizer, Lilly India +37 more (view full list)
SIC	SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies
NAICS	NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies